Melatonin

Category
sleep
Half-Life (t½)
PO: 42m · SL: 30m
Formula
C13H16N2O2
Molecular Weight
232.28 g/mol
PubChem CID
896

Pharmacological Mechanism

MT1/MT2 agonist; entrains the circadian clock bmal1 per cry circadian rhythm.

Half-Life & Elimination Curve (PO: 42m · SL: 30m)

100%50%25%12.5%0%0h0×t½42m1×t½1.4h2×t½2.1h3×t½2.8h4×t½3.5h5×t½0×t½ (0h): 100% remaining (~1.24 µg/L)1×t½ (42m): 50% remaining (~0.621 µg/L)2×t½ (1.4h): 25% remaining (~0.31 µg/L)3×t½ (2.1h): 12.5% remaining (~0.155 µg/L)4×t½ (2.8h): 6.3% remaining (~0.0776 µg/L)5×t½ (3.5h): 3.1% remaining (~0.0388 µg/L)
Plasma (PO)t½ Decay (42m)Effect Site (ke0)
  • 0×t½0h100% (1.24 µg/L)
  • 1×t½42m50% (0.621 µg/L)
  • 2×t½1.4h25% (0.31 µg/L)
  • 3×t½2.1h12.5% (0.155 µg/L)
  • 4×t½2.8h6.3% (0.0776 µg/L)
  • 5×t½3.5h3.1% (0.0388 µg/L)
Elimination t½42m (PO)
Rate Constant (ke)0.99 h⁻¹
Time to Peak (Tmax)33m
Est. Peak (Cmax)1.24 µg/L
Clearance (CL)34.7 L/h
97% Washout (5×t½)3.5h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Notes

Lower doses (0.3mg) often outperform high doses for sleep onset. PO has heavy first-pass; SL bypasses much of it. MT1 Ki ~80 pM = 0.0000186 mg/L, MT2 Ki ~270 pM = 0.0000626 mg/L (melatonin MW 232 g/mol). Therapeutic plasma at 0.5 mg PO peaks ~80-100 pg/mL = ~1e-4 mg/L, well above both receptor EC50s — both are saturated within minutes of dosing.

Chemical Structure & Identifiers

References